319 related articles for article (PubMed ID: 9753691)
21. Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases.
Salituro FG; Germann UA; Wilson KP; Bemis GW; Fox T; Su MS
Curr Med Chem; 1999 Sep; 6(9):807-23. PubMed ID: 10495353
[TBL] [Abstract][Full Text] [Related]
22. Enzyme-linked immunosorbent assay for measurement of JNK, ERK, and p38 kinase activities.
Forrer P; Tamaskovic R; Jaussi R
Biol Chem; 1998; 379(8-9):1101-11. PubMed ID: 9792443
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of p38 MAP kinase as a therapeutic strategy.
Lee JC; Kumar S; Griswold DE; Underwood DC; Votta BJ; Adams JL
Immunopharmacology; 2000 May; 47(2-3):185-201. PubMed ID: 10878289
[TBL] [Abstract][Full Text] [Related]
24. Cross-interactions of two p38 mitogen-activated protein (MAP) kinase inhibitors and two cholecystokinin (CCK) receptor antagonists with the CCK1 receptor and p38 MAP kinase.
Morel C; Ibarz G; Oiry C; Carnazzi E; Bergé G; Gagne D; Galleyrand JC; Martinez J
J Biol Chem; 2005 Jun; 280(22):21384-93. PubMed ID: 15772081
[TBL] [Abstract][Full Text] [Related]
25. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases.
Goedert M; Cuenda A; Craxton M; Jakes R; Cohen P
EMBO J; 1997 Jun; 16(12):3563-71. PubMed ID: 9218798
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of p38 MAP kinase increases okadaic acid mediated AP-1 expression and DNA binding but has no effect on TRE dependent transcription.
Rosenberger SF; Gupta A; Bowden GT
Oncogene; 1999 Jun; 18(24):3626-32. PubMed ID: 10380884
[TBL] [Abstract][Full Text] [Related]
27. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho.
Pfeiffer ZA; Aga M; Prabhu U; Watters JJ; Hall DJ; Bertics PJ
J Leukoc Biol; 2004 Jun; 75(6):1173-82. PubMed ID: 15075366
[TBL] [Abstract][Full Text] [Related]
28. P38 MAP kinase inhibitors: evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes.
Natarajan SR; Doherty JB
Curr Top Med Chem; 2005; 5(10):987-1003. PubMed ID: 16178742
[TBL] [Abstract][Full Text] [Related]
29. The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation.
Bellon S; Fitzgibbon MJ; Fox T; Hsiao HM; Wilson KP
Structure; 1999 Sep; 7(9):1057-65. PubMed ID: 10508788
[TBL] [Abstract][Full Text] [Related]
30. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway.
Rincón M; Enslen H; Raingeaud J; Recht M; Zapton T; Su MS; Penix LA; Davis RJ; Flavell RA
EMBO J; 1998 May; 17(10):2817-29. PubMed ID: 9582275
[TBL] [Abstract][Full Text] [Related]
31. Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580.
Eyers PA; van den IJssel P; Quinlan RA; Goedert M; Cohen P
FEBS Lett; 1999 May; 451(2):191-6. PubMed ID: 10371163
[TBL] [Abstract][Full Text] [Related]
32. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions.
Adachi T; Choudhury BK; Stafford S; Sur S; Alam R
J Immunol; 2000 Aug; 165(4):2198-204. PubMed ID: 10925307
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle.
Hallsworth MP; Moir LM; Lai D; Hirst SJ
Am J Respir Crit Care Med; 2001 Aug; 164(4):688-97. PubMed ID: 11520738
[TBL] [Abstract][Full Text] [Related]
34. PMA-induced activation of the p42/44ERK- and p38RK-MAP kinase cascades in HL-60 cells is PKC dependent but not essential for differentiation to the macrophage-like phenotype.
Schultz H; Engel K; Gaestel M
J Cell Physiol; 1997 Dec; 173(3):310-8. PubMed ID: 9369943
[TBL] [Abstract][Full Text] [Related]
35. Calmodulin-dependent activation of p38 and p42/44 mitogen-activated protein kinases contributes to c-fos expression by calcium in PC12 cells: modulation by nitric oxide.
Lee SA; Park JK; Kang EK; Bae HR; Bae KW; Park HT
Brain Res Mol Brain Res; 2000 Jan; 75(1):16-24. PubMed ID: 10648884
[TBL] [Abstract][Full Text] [Related]
36. Kinetic mechanism for p38 MAP kinase.
LoGrasso PV; Frantz B; Rolando AM; O'Keefe SJ; Hermes JD; O'Neill EA
Biochemistry; 1997 Aug; 36(34):10422-7. PubMed ID: 9265622
[TBL] [Abstract][Full Text] [Related]
37. Potent inhibitors of the MAP kinase p38.
Henry JR; Rupert KC; Dodd JH; Turchi IJ; Wadsworth SA; Cavender DE; Schafer PH; Siekierka JJ
Bioorg Med Chem Lett; 1998 Dec; 8(23):3335-40. PubMed ID: 9873730
[TBL] [Abstract][Full Text] [Related]
38. p38 MAP kinase regulates TNF alpha-, IL-1 alpha- and PAF-induced RANTES and GM-CSF production by human bronchial epithelial cells.
Hashimoto S; Matsumoto K; Gon Y; Maruoka S; Kujime K; Hayashi S; Takeshita I; Horie T
Clin Exp Allergy; 2000 Jan; 30(1):48-55. PubMed ID: 10606930
[TBL] [Abstract][Full Text] [Related]
39. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1.
Matthews JS; O'Neill LA
Cytokine; 1999 Sep; 11(9):643-55. PubMed ID: 10479400
[TBL] [Abstract][Full Text] [Related]
40. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
